3 stocks to help you retire early

Retirement planning requires a long-term view and these three shares could bring retirement a big step closer.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

For most people, retiring early is a major goal in life. Investing in shares can help you to achieve that, but these three stocks could help you to do so a few years earlier than you expected.

AstraZeneca

AstraZeneca (LSE: AZN) has endured a challenging period due to its loss of patents on key, blockbuster drugs in recent years. This has caused a large fall in profitability, which has hurt investor sentiment to a degree. However, this weakening of investor sentiment has been more than offset by optimism towards AstraZeneca’s acquisition strategy. The company has made full use of its strong cash flow and sound finances to transform its pipeline so that it’s now all set to deliver positive growth over the medium-to-long term.

Allied to this is AstraZeneca’s income potential. It currently yields 4.1% and with dividends being covered 1.5 times, they’re very sustainable. This mix of income return plus the potential for strong growth from its new pipeline of treatments means that AstraZeneca could soar over the long run and help you retire early.

Compass

One thing that’s of great benefit to long-term investors is consistency. On this front, Compass (LSE: CPG) has huge appeal since it has an excellent track record of earnings growth. In fact, over the last five years its bottom line has increased in each year, with an annualised earnings growth rate of 8.3% during the period. This bodes well for its future returns, since it shows that it can operate in a range of economic conditions and still turn a rising profit.

The food services industry provides Compass with a relatively dependable financial outlook. That’s because demand is quite resilient and with the outlook for the UK economy being uncertain due in part to Brexit, this could cause investor sentiment towards Compass to improve. Its yield of 2.2% may be lower than the FTSE 100’s yield of 3.5%, but with dividends being covered 1.9 times by profit, there’s scope for shareholder payouts to rise by at least as much as profit over the long run.

Sainsbury’s

Although the UK retail sector faces an uncertain future, Sainsbury’s (LSE: SBRY) has the right strategy to perform well. Its pricing is simple and focuses on offering value for money rather than chasing low prices, while its acquisition of Argos owner Home Retail provides growth potential. The synergies between the two companies are significant and there are major cross-selling opportunities that could boost Sainsbury’s bottom line over the medium-to-long term.

Sainsbury’s yields 4.4% at the present time and its dividends are covered twice by profit. While dividend growth may be somewhat low in the near term due to the uncertain operating environment it faces, Sainsbury’s has significant headroom when making dividend payments and this could lead to a rapidly rising income return over the coming years. Therefore, it offers excellent total return potential and alongside Compass and AstraZeneca, could help you retire early.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Peter Stephens owns shares of AstraZeneca and Sainsbury (J). The Motley Fool UK has recommended AstraZeneca. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Fireworks display in the shape of willow at Newcastle, Co. Down , Northern Ireland at Halloween.
Investing Articles

The Anglo American share price soars to £25, but I’m not selling!

On Thursday, the Anglo American share price soared after mega-miner BHP Group made an unsolicited bid for it. But I…

Read more »

Investing Articles

Now 70p, is £1 the next stop for the Vodafone share price?

The Vodafone share price is back to 70p, but it's a long way short of the 97p it hit in…

Read more »

Concept of two young professional men looking at a screen in a technological data centre
Investing Articles

If I’d put £5,000 in Nvidia stock at the start of 2024, here’s what I’d have now

Nvidia stock was a massive winner in 2023 as the AI chipmaker’s profits surged across the year. How has it…

Read more »

Light bulb with growing tree.
Investing Articles

3 top investment trusts that ‘green’ up my Stocks and Shares ISA

I’ll be buying more of these investment trusts for my Stocks and Shares ISA given the sustainable and stable returns…

Read more »

Investing Articles

8.6% or 7.2%? Does the Legal & General or Aviva dividend look better?

The Aviva dividend tempts our writer. But so does the payout from Legal & General. Here he explains why he'd…

Read more »

a couple embrace in front of their new home
Investing Articles

Are Persimmon shares a bargain hiding in plain sight?

Persimmon shares have struggled in 2024, so far. But today's trading update suggests sentiment in the housing market's already improving.

Read more »

Market Movers

Here’s why the Unilever share price is soaring after Q1 earnings

Stephen Wright isn’t surprised to see the Unilever share price rising as the company’s Q1 results show it’s executing on…

Read more »

Investing Articles

Barclays’ share price jumps 5% on Q1 news. Will it soon be too late to buy?

The Barclays share price has been having a great time this year, as a solid Q1 gives it another boost.…

Read more »